Longboat Clinical has launched Patient CONNECT, a unique solution to ease the process of patient recruitment into clinical trials.
The Patient CONNECT approach provides much-in-demand insights to drug development teams.
This solution is a new addition to the Longboat’s portfolio, connecting patients interested in a particular study directly with enrolling sites. It allows the participants to provide their contact details to site staff via an actionable dashboard.
Longboat head of client services and innovation Aidan Gannon said: “We designed Patient CONNECT to remove the frustrations around the use of online patient recruitment campaigns.
“For patients, it can be a disjointed, impersonal experience: site staff do not always receive timely notifications of interested patients and then struggle to find their contact details; and for study teams, it is difficult to address issues with online solutions without real-time access to data and performance metrics.”
Patient CONNECT can be integrated into any third-party online environment, which enables eligible patients to self-screen for a study, and submit their contact details to respective enrolling site sites.
Through the Patient CONNECT technology, patient enrolling sites will immediately be notified of new patients and can access the details securely, via the Longboat dashboard.
The Longboat dashboard will enable the participating sites to log the status of each referral through the screening and enrolling process.
Gannon added: “Sponsors don’t always have oversight of their digital outreach campaigns. Patient CONNECT captures all data, from patient behaviors, global site metrics and the conversion rate of each step on the journey in a way that also simplifies the process for sites and patients.”
The user-friendly solution features an intuitive interface.
Based in Dublin, Longboat Clinical is a clinical trials software company specialising in site and patient engagement platforms.